Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Patient Safety Strategy Would Shift AE Monitoring To Automated Systems

Executive Summary

FDA plans to unveil a broad patient safety strategy over the next few months that will explain how the agency plans to move away from reliance on voluntary reporting to use of automated systems to collect adverse event and medical errors data
Advertisement

Related Content

FDA Plan Seeks Better, Not Burdensome, Data Collection, McClellan Says
PhRMA-FDA Working Group To Develop Best Practices For Data Mining
PhRMA-FDA Working Group To Develop Best Practices For Data Mining
FDA Plan Seeks Better, Not Burdensome, Data Collection, McClellan Says
FDA Medical Error Proposal Requires Reporting “Near-Misses” Within 15 Days
FDA Risk Management Plan: Four Levels, From Labeling To Restricted Access
Patient Safety Bills: House Commerce Cmte. Goes First, Requires Bar Codes
McClellan’s “Smart Regulation”: More Early Testing And Phase IV Studies
McClellan’s “Smart Regulation”: More Early Testing And Phase IV Studies
Advertisement
UsernamePublicRestriction

Register

PS041521

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel